The reason why the observational BC cardiotoxicity trial was scrapped appears to be that the degree of cardioprotection will be measured by varying the bisantrene dose.
Buy, Held
Ann: Race Strategic Update August 2023, page-10
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.045(3.46%) |
Mkt cap ! $216.0M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.30 | $1.25 | $77.93K | 61.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1861 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 5256 | 1 |
View Market Depth
| Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.25 |
Change
-0.045 ( 1.91 %) |
||||
| Open | High | Low | Volume | ||
| $1.27 | $1.29 | $1.25 | 5875 | ||
| Last updated 15.55pm 30/04/2024 ? | |||||
| RAC (ASX) Chart |